Heron Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Heron Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Heron Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.8k | 2.9k | 1.99 |
| 2024-06-30 | $185k | 53k | 3.50 |
| 2024-03-31 | $5.5k | 2.0k | 2.77 |
| 2023-09-30 | $9.5k | 9.2k | 1.03 |
| 2023-03-31 | $36k | 24k | 1.51 |
| 2022-09-30 | $3.0k | 800 | 3.75 |
| 2022-06-30 | $1.0k | 200 | 5.00 |
| 2022-03-31 | $55k | 9.7k | 5.67 |
| 2021-12-31 | $126k | 14k | 9.13 |
| 2021-09-30 | $127k | 12k | 10.67 |
| 2021-06-30 | $521k | 34k | 15.51 |
| 2021-03-31 | $204k | 13k | 16.19 |
| 2020-12-31 | $212k | 10k | 21.20 |
| 2020-09-30 | $252k | 17k | 14.82 |
| 2020-06-30 | $1.2M | 84k | 14.71 |
| 2020-03-31 | $872k | 74k | 11.74 |
| 2019-12-31 | $263k | 11k | 23.48 |
| 2019-09-30 | $427k | 23k | 18.48 |
| 2019-06-30 | $231k | 12k | 18.63 |
| 2019-03-31 | $303k | 12k | 24.44 |
| 2018-12-31 | $231k | 8.9k | 25.96 |
| 2018-09-30 | $601k | 19k | 31.63 |
| 2018-06-30 | $4.4M | 114k | 38.85 |
| 2018-03-31 | $3.0M | 109k | 27.60 |
| 2017-12-31 | $898k | 50k | 18.10 |
| 2017-09-30 | $36k | 2.2k | 16.36 |
| 2017-06-30 | $93k | 6.7k | 13.88 |
| 2017-03-31 | $209k | 14k | 15.04 |
| 2016-12-31 | $741k | 57k | 13.09 |
| 2016-09-30 | $227k | 13k | 17.20 |
| 2016-06-30 | $2.8M | 155k | 18.05 |
| 2016-03-31 | $712k | 38k | 18.99 |
| 2015-12-31 | $80k | 3.0k | 26.67 |
| 2015-09-30 | $8.6M | 353k | 24.40 |
| 2015-06-30 | $3.8M | 123k | 31.16 |
| 2015-03-31 | $113k | 7.8k | 14.49 |
| 2014-09-30 | $8.0k | 1.0k | 8.00 |
| 2014-06-30 | $12k | 1.0k | 12.00 |
Top funds holding Heron Therapeutics
View all funds holding Heron Therapeutics